Cathie Wood's $362 Million CRISPR Bet: Hidden Catalyst
Cathie Wood’s big bet on CRISPR Therapeutics signals more than faith in gene editing. This article digs into the unde...
Learn the key factors to inspect when comparing funds, including costs, performance, and risk, to make informed investment choices.
18,912 articlesCathie Wood’s big bet on CRISPR Therapeutics signals more than faith in gene editing. This article digs into the unde...
Traditional media is fading as a pillar of democratic information, pushing investors to rethink exposure and resilien...
AI momentum is reshaping the market today. We break down what’s moving stocks, why tech names are rallying, and how i...
As Xometry heads into 2025 earnings, investors seek clarity on growth, margins, and execution. This guide provides ac...
Remote work demand worldwide is shifting how companies hire, spend, and allocate capital. This in-depth guide breaks ...
BigBear.ai has emerged as a key name in enterprise AI and decision intelligence. This guide breaks down bigbear.ai (b...
In a market full of headlines, some of the best gains come from stocks that fly under the radar. This guide shows you...
Plug Power recently beat quarterly estimates, but that isn’t a guarantee the stock is safe to buy. This guide breaks ...
Insider stock moves can spark questions about a company's future. This guide breaks down what viasat's chief accounti...
The AI wave doesn’t have to ride on flashy tech stocks. This article shows how certain energy stocks can capture AI-d...
Oracle has fallen this year as investors weigh legacy strengths against AI disruption. This guide breaks down the AI ...
Disney, McDonald’s, Microsoft, and Procter & Gamble now appear oversold despite solid earnings and durable consumer s...